Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Assessing safety means examining volatility, drawdown risk, and income prospects of index funds versus bonds to determine the calmer route for retirement.
23,779 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
Two insurance giants reveal how revenue trends shape investor returns. This guide breaks down who earns more, where p...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...
California is backing electric vehicle buyers with a new point-of-sale rebate program. For Rivian, this policy shift ...
A broader AI software sell-off created a rare opportunity for long-term investors. Here are three blue-chip options t...
Investors are asking whether the AI infrastructure boom is a bubble. This article dives into real-world data, global ...
A 34% jump in urea prices amid Iran tensions is sending shockwaves beyond farming. This article breaks down how ferti...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...